Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 32.85
+2.21 (7.21%)
At close: Apr 22, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 122.9 million as of April 22, 2026. Its market cap has decreased by -23.52% in one year.
Market Cap
122.90M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
32.85
Market Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 122.90M, an increase of 80.99%. That is a compound annual growth rate of 9.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 122.90M | -2.90% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenith Healthcare | 170.89M |
| Norris Medicines | 152.51M |
| Desh Rakshak Aushdhalaya | 139.89M |
| Emmessar Biotech & Nutrition | 134.69M |
| Beryl Drugs | 125.27M |
| Ortin Global | 121.97M |
| Shamrock Industrial Company | 115.99M |
| Colinz Laboratories | 115.88M |